COMMUNIQUÉS West-GlobeNewswire

Galecto Reports First Quarter 2025 Operating and Financial Results
08/05/2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and [...]
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
08/05/2025
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08 [...]
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
08/05/2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, [...]
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
08/05/2025
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO- [...]
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
08/05/2025
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing [...]
Tarsus to Participate in Upcoming Investor Conferences
08/05/2025
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America [...]
VitalHub Reports First Quarter 2025 Results
08/05/2025
Annual Recurring Revenue (ARR) ⁽¹⁾ up 54% YoY to $73.7 million Total Revenue up 42% YoY to $21.7 million Adjusted EBITDA ⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “ [...]
Nova Leap Health Corp. Posts Q1 2025 Results
08/05/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
08/05/2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed ® for first-line infertility treatment and FemBloc ® non-surgical permanent birth control (full system approval [...]
Keros Reinforces Commitment to Maximizing Stockholder Value
08/05/2025
Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting “FOR” the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- [...]
Genmab Announces Financial Results for the First Quarter of 2024
08/05/2025
May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025 Highlights EPKINLY ® (epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional indication [...]
Acentra Health Supports Utah in Securing CMS Certification for Medicaid Enterprise System Modernization
08/05/2025
Milestone highlights Acentra Health’s pivotal role in supporting state Medicaid modernization and eligibility platform transformation MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
Kriya Presents Data at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
08/05/2025
– Preclinical data support clinical development of KRIYA-825; Phase 1/2 clinical trial in Geographic Atrophy currently underway – – Kriya is developing KRIYA-825 as a potential one-time gene therapy, delivered by [...]
Press release: Transparency Notification from Shareholders
08/05/2025
Transparency Notification from Shareholders Ghent, Belgium – 8 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
Clue Launches "Connect the Dots" Campaign for Mental Health Awareness Month, Highlighting the Critical Link Between Menstrual Cycles and Mental Wellbeing
08/05/2025
BERLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Clue , the most trusted, data-driven period and reproductive health tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month. The campaign [...]
Philips shareholders approve all proposals at the AGM 2025
08/05/2025
May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re- [...]
Mapping the Code of Life: European Wellness Highlights 400+ Human Cell Types in Landmark Cytology Atlas
08/05/2025
HEIDELBERG, Germany , May 08, 2025 (GLOBE NEWSWIRE) -- A landmark scientific breakthrough has mapped over 400 human cell types — offering powerful confirmation for the precision medicine philosophy Prof. Mike Chan has [...]
Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering
08/05/2025
SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“ Cuprina ” or “the Company ”), a biomedical and biotechnology company dedicated to the development and commercialization of [...]
The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support
08/05/2025
CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of Directors: John Mockovciak III, Joan Levy, PhD, John [...]

Pages